Conal Cram

Conal is a seasoned tech industry professional and content writer for numerous tech publications. With a strong background in software engineering and digital media development, he's passionate about sharing the latest updates and insights in the tech industry, particularly in artificial intelligence and other disruptive trends. In his spare time he loves a mezze platter and a good film, and if he's not playing Fortnite or spending time with his daughter you can assume he's at the dry slopes!
Follow:
45 Articles

Genome Medical Boosts Genomics with Clinical-Grade Data for Better Trial Matching

Genome Medical is transforming the field of genomics by making genetics care…

Conal Cram Conal Cram

Former AstraZeneca Executive Dr. Hazel Jones Appointed CEO at Enhanc3D Genomics

Enhanc3D Genomics has appointed former AstraZeneca executive, Dr. Hazel Jones, as its…

Conal Cram Conal Cram

Revolutionizing Hydrogel Creation with Computer-Designed Proteins: Bridging the Gap in Biomedical Innovation

Hydrogels, with their unique ability to mimic the cellular environment, have emerged…

Conal Cram Conal Cram

New Insights in Fragile X Syndrome: Groundbreaking Study

Introduction to Fragile X Syndrome In a remarkable advancement for genetic research,…

Conal Cram Conal Cram

Actin Isoforms’ Tiny Variations Yield Significant Cellular Impacts

Introduction In the intricate world of cellular biology, even the slightest variations…

Conal Cram Conal Cram

Immunis Triumphs with BASA Biotech Awards: Leading in Innovation

IRVINE, Calif., December 20, 2023 – Immunis Inc., a trailblazer in the…

Conal Cram Conal Cram

Helix & Sanford Health Launch Pioneering Genomics Program in Rural U.S.

In a groundbreaking initiative, Helix, a leader in population genomics, joins forces…

Conal Cram Conal Cram

Molecular Loop Biosciences receives $1.8 million grant from the Gates Foundation to propel multi-pathogen genomics

Introduction: A New Era in Pathogen Genomics In a significant development for…

Conal Cram Conal Cram

Revolutionary Phase II Trial by Puma Biotechnology for Breast Cancer

Puma Biotechnology's Pioneering Clinical Trial Puma Biotechnology, a renowned US-based biopharmaceutical company,…

Conal Cram Conal Cram